International Journal of Cancer Management

Published by: Kowsar

Cytotoxic Effect of Emodin on Growth of SKBR3 Breast Cancer Cells

Maryam Rezapour Kalkhoran 1 , Faranak Kazerouni 1 , * , Mir Davood Omrani 3 , Ali Rahimipour 1 , Mehrnoosh Shanaki 1 , Nasrin Dehghan-Nayeri 4 , Farzaneh Ahmadi 2 , Ommolbanin Younesian 1 and Fatemeh Cheshmi 1
Authors Information
1 Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Medical Genetics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Proteomics Research Center, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: April 2017, 10 (4); e8094
  • Published Online: March 26, 2017
  • Article Type: Research Article
  • Received: August 9, 2016
  • Revised: September 11, 2016
  • Accepted: March 14, 2017
  • DOI: 10.5812/ijcm.8094

To Cite: Rezapour Kalkhoran M, Kazerouni F, Omrani M D, Rahimipour A, Shanaki M, et al. Cytotoxic Effect of Emodin on Growth of SKBR3 Breast Cancer Cells, Int J Cancer Manag. 2017 ; 10(4):e8094. doi: 10.5812/ijcm.8094.

Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1): 10-29[DOI][PubMed]
  • 2. Jazayeri SB, Saadat S, Ramezani R, Kaviani A. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer Epidemiol. 2015; 39(4): 519-27[DOI][PubMed]
  • 3. Hosseini A, Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed. 2015; 5(2): 84-97[PubMed]
  • 4. Wu TS, Jiang ZS, Meng CY. Pharmacosomes of Emodin in Improving Paraplegia in Traumatic Spinal Cord Injury Rat Model. J Biomaterials Tissue Engin. 2015; 5(12): 991-5[DOI]
  • 5. Wei WT, Lin SZ, Liu DL, Wang ZH. The distinct mechanisms of the antitumor activity of emodin in different types of cancer (Review). Oncol Rep. 2013; 30(6): 2555-62[DOI][PubMed]
  • 6. Kurebayashi J. Biological and clinical significance of HER2 overexpression in breast cancer. Breast Cancer. 2001; 8(1): 45-51[PubMed]
  • 7. Thacker PC, Karunagaran D. Curcumin and emodin down-regulate TGF-beta signaling pathway in human cervical cancer cells. PLoS One. 2015; 10(3)[DOI][PubMed]
  • 8. Liu B, Yuan B, Zhang L, Mu W, Wang C. ROS/p38/p53/Puma signaling pathway is involved in emodin-induced apoptosis of human colorectal cancer cells. Int J Clin Exp Med. 2015; 8(9): 15413-22[PubMed]
  • 9. Ying J, Xu H, Wu D, Wu X. Emodin induces apoptosis of human osteosarcoma cells via mitochondria- and endoplasmic reticulum stress-related pathways. Int J Clin Exp Pathol. 2015; 8(10): 12837-44[PubMed]
  • 10. Wang C, Dai X, Liu H, Yi H, Zhou D, Liu C, et al. Involvement of PPARgamma in emodin-induced HK-2 cell apoptosis. Toxicol In Vitro. 2015; 29(1): 228-33[DOI][PubMed]
  • 11. Xie MJ, Ma YH, Miao L, Wang Y, Wang HZ, Xing YY, et al. Emodin-provoked oxidative stress induces apoptosis in human colon cancer HCT116 cells through a p53-mitochondrial apoptotic pathway. Asian Pac J Cancer Prev. 2014; 15(13): 5201-5[PubMed]
  • 12. Agnihotri AK, Aruoma OI, Bahorun T. Cancer: Global health perspectives. Arch Med Biomed Res. 2014; 1(1): 1-9
  • 13. Liao GS, Apaya MK, Shyur LF. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement Alternat Med. 2013; 2013: 437948[DOI][PubMed]
  • 14. Richard TS, Kamdje AHN, Mukhtar F. Medicinal plants in breast cancer therapy. J Dis Med Plants. 2015; 1: 19-23
  • 15. Chen YC, Shen SC, Lee WR, Hsu FL, Lin HY, Ko CH, et al. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol. 2002; 64(12): 1713-24[PubMed]
  • 16. Su YT, Chang HL, Shyue SK, Hsu SL. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol. 2005; 70(2): 229-41[DOI][PubMed]
  • 17. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. 2004; 53(3): 153-9[DOI][PubMed]
  • 18. Westhoff MA, Karpel-Massler G, Bruhl O, Enzenmuller S, La Ferla-Bruhl K, Siegelin MD, et al. A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy. Mol Cell Ther. 2014; 2: 32[DOI][PubMed]
  • 19. Liu DL, Bu H, Li H, Chen H, Guo HC, Wang ZH, et al. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Int J Oncol. 2012; 40(4): 1049-57[DOI][PubMed]
  • 20. Zu C, Zhang M, Xue H, Cai X, Zhao L, He A, et al. Emodin induces apoptosis of human breast cancer cells by modulating the expression of apoptosis-related genes. Oncol Lett. 2015; 10(5): 2919-24[DOI][PubMed]
  • 21. Yu CX, Zhang XQ, Kang LD, Zhang PJ, Chen WW, Liu WW, et al. Emodin induces apoptosis in human prostate cancer cell LNCaP. Asian J Androl. 2008; 10(4): 625-34[DOI][PubMed]
  • 22. Chun-Guang W, Jun-Qing Y, Bei-Zhong L, Dan-Ting J, Chong W, Liang Z, et al. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Eur J Pharmacol. 2010; 627(1-3): 33-41[DOI][PubMed]
  • 23. Ma L, Li W. Emodin inhibits LOVO colorectal cancer cell proliferation via the regulation of the Bcl-2/Bax ratio and cytochrome c. Exp Ther Med. 2014; 8(4): 1225-8[DOI][PubMed]
  • 24. Miyata Y, Sakai H. Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy. Dis Markers. 2015; 2015: 857416[DOI][PubMed]
  • 25. Giotakis AI, Kontos CK, Manolopoulos LD, Sismanis A, Konstadoulakis MM, Scorilas A. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis. Clin Biochem. 2016; 49(12): 890-6[DOI][PubMed]
  • 26. Anvari K, Seilanian Toussi M, Kalantari M, Naseri S, Karimi Shahri M, Ahmadnia H, et al. Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma. Urol J. 2012; 9(1): 381-8[PubMed]
  • 27. Wang C, Wu X, Chen M, Duan W, Sun L, Yan M, et al. Emodin induces apoptosis through caspase 3-dependent pathway in HK-2 cells. Toxicology. 2007; 231(2-3): 120-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments